BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 15.4//EN
BEGIN:VTIMEZONE
TZID:GMT Standard Time
BEGIN:STANDARD
DTSTART:20251002T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=10
TZNAME:GMT Standard Time
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T010000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYHOUR=1;BYMINUTE=0;BYMONTH=3
TZNAME:GMT Daylight Time
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Date:&nbsp\;10th December 2019\nTime: 14:00 - 15:30\nSpeakers:&
 nbsp\;PSI/EFSPI SIG Quantitative Decision-Making members:\n\n\n\n\n    Pie
 rre Colin (Sanofi)\n    Juan Abellan (GSK)\n    Ga&euml\;lle Saint-Hilary 
 (Servier)\n\nQuantitative methods to support decision-making in clinical d
 rug development already exist\, but may be unknown or unused by pharmaceut
 ical companies. We performed a survey among pharmaceutical companies\, tar
 geting people with different profiles (statisticians\, non-statisticians a
 nd decision-makers) working at different stages of the clinical developmen
 t (study level\, development level or portfolio level). This survey allowe
 d us to analyze which quantitative methods are known\, which quantitative 
 methods are used (or not)\, what benefit is expected from this kind of met
 hods\, and what are the needs for a larger use of quantitative methods to 
 support decision-making. It permitted to understand the gaps and some of t
 he issues associated to the use of such methods in drug development. The w
 ebinars are intended to share the learnings from the survey and to promote
  different quantitative methods for decision-making.\nRegistration:&nbsp\;
 To register for this free webinar\, please&nbsp\;click here.\n\nPlease ema
 il&nbsp\;PSI@mci-group.com&nbsp\;if you have any questions.
DTEND:20191210T153000Z
DTSTAMP:20260517T055000Z
DTSTART:20191210T140000Z
LOCATION:
SEQUENCE:0
SUMMARY:PSI Webinar - Main statistical approaches for quantitative decision
 -making in drug development
UID:RFCALITEM639145938002840051
X-ALT-DESC;FMTTYPE=text/html:<p><strong>Date:&nbsp\;</strong><strong>10th D
 ecember 2019<br />\nTime: 14:00 - 15:30<br />\nSpeakers:&nbsp\;<strong>PSI
 /EFSPI SIG Quantitative Decision-Making members:<br />\n<br />\n<img src="
 https://www.psiweb.org/images/default-source/default-album/speakers.png?sf
 vrsn=46e6dadb_0&sf_site_temp=true&sf_site=00000000-0000-0000-0000-00000000
 0000" data-displaymode="Original" alt="speakers" title="speakers" /><br />
 \n</strong></strong></p>\n<ul>\n    <li>Pierre Colin (Sanofi)</li>\n    <l
 i>Juan Abellan (GSK)</li>\n    <li>Ga&euml\;lle Saint-Hilary (Servier)</li
 >\n</ul>\n<p><strong></strong>Quantitative methods to support decision-mak
 ing in clinical drug development already exist\, but may be unknown or unu
 sed by pharmaceutical companies. We performed a survey among pharmaceutica
 l companies\, targeting people with different profiles (statisticians\, no
 n-statisticians and decision-makers) working at different stages of the cl
 inical development (study level\, development level or portfolio level). T
 his survey allowed us to analyze which quantitative methods are known\, wh
 ich quantitative methods are used (or not)\, what benefit is expected from
  this kind of methods\, and what are the needs for a larger use of quantit
 ative methods to support decision-making. It permitted to understand the g
 aps and some of the issues associated to the use of such methods in drug d
 evelopment. The webinars are intended to share the learnings from the surv
 ey and to promote different quantitative methods for decision-making.</p>\
 n<p><strong>Registration:</strong>&nbsp\;To register for this free webinar
 \, please&nbsp\;<a href="https://members.psiweb.org/Core_Content_PSI/Event
 s/Event_Display.aspx?EventKey=202">click here.</a><br />\n<br />\nPlease e
 mail&nbsp\;<a href="mailto:PSI@mci-group.com">PSI@mci-group.com</a>&nbsp\;
 if you have any questions<strong>.</strong></p>
END:VEVENT
END:VCALENDAR